Use of molecular docking computational tools in drug discovery

F Stanzione, I Giangreco, JC Cole - Progress in medicinal chemistry, 2021 - Elsevier
Molecular docking has become an important component of the drug discovery process.
Since first being developed in the 1980s, advancements in the power of computer hardware …

Cathepsins and SARS‐CoV‐2 infection: From pathogenic factors to potential therapeutic targets

S Zhao, M Jiang, H Qing, J Ni - British Journal of Pharmacology, 2023 - Wiley Online Library
Abstract Coronavirus disease‐19 (COVID‐19) is caused by severe acute respiratory
syndrome‐coronavirus‐2 (SARS‐CoV‐2) infection. The COVID‐19 pandemic began in …

[HTML][HTML] Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum …

AA Alzain, FA Elbadwi, FO Alsamani - Informatics in Medicine Unlocked, 2022 - Elsevier
The global expansion of COVID-19 and the mutations of severe acute respiratory syndrome
coronavirus necessitate quick development of treatment and vaccination. Because the …

Antiviral activities of 4H-chromen-4-one scaffold-containing flavonoids against SARS–CoV–2 using computational and in vitro approaches

V Raj, JH Lee, JJ Shim, J Lee - Journal of Molecular Liquids, 2022 - Elsevier
The widespread outbreak of the novel coronavirus called severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) has caused the main health challenge worldwide. This …

Discovery of druggable potent inhibitors of serine proteases and farnesoid X receptor by ligand-based virtual screening to obstruct SARS-CoV-2

S Zaib, N Rana, HS Ali, N Hussain, HA Ogaly… - International Journal of …, 2023 - Elsevier
The coronavirus, a subfamily of the coronavirinae family, is an RNA virus with over 40
variations that can infect humans, non-human mammals and birds. There are seven types of …

Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics

RS Cheke, PS Kharkar - Drug Development Research, 2024 - Wiley Online Library
Covalent inhibitors have been used to treat several diseases for over a century. However,
strategic approaches for the rational design of covalent drugs have taken a definitive shape …

Advanced approaches of developing targeted covalent drugs

C Gai, SJ Harnor, S Zhang, C Cano, C Zhuang… - RSC Medicinal …, 2022 - pubs.rsc.org
In recent years, the development of targeted covalent inhibitors has gained popularity
around the world. Specific groups (electrophilic warheads) form irreversible bonds with the …

Molecular modeling targeting Transmembrane Serine Protease 2 (TMPRSS2) as an alternative drug target against coronaviruses

IJ dos Santos Nascimento… - Current drug …, 2022 - ingentaconnect.com
Since December 2019, the new Coronavirus disease (COVID-19) caused by the etiological
agent SARS-CoV-2 has been responsible for several cases worldwide, becoming pandemic …

Recent status of sesaminol and its glucosides: Synthesis, metabolism, and biological activities

QZ Li, ZW Zuo, Y Liu - Critical Reviews in Food Science and …, 2023 - Taylor & Francis
Sesamum indicum is a major and important oilseed crop that is believed to promote human
health in many countries, especially in China. Sesame seeds contain two types of lignans …

[HTML][HTML] Docking-generated multiple ligand poses for bootstrapping bioactivity classifying Machine Learning: Repurposing covalent inhibitors for COVID-19-related …

MH Ma'mon, O Abuyaman, M Taha - Computational and Structural …, 2021 - Elsevier
In the present work we introduce the use of multiple docked poses for bootstrapping
machine learning-based QSAR modelling. Ligand-receptor contact fingerprints are …